Scotia Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Hold |
31,589
| – | – | ﹤0.01% | 723 |
|
|
2025
Q1 | $171K | Buy |
31,589
+19,168
| +154% | +$104K | ﹤0.01% | 794 |
|
|
2024
Q4 | $92.5K | Hold |
12,421
| – | – | ﹤0.01% | 822 |
|
|
2024
Q3 | $99.2K | Hold |
12,421
| – | – | ﹤0.01% | 805 |
|
|
2024
Q2 | $108K | Buy |
+12,421
| New | +$108K | ﹤0.01% | 794 |
|
|
2024
Q1 | – | Sell |
-8,963
| Closed | -$207K | – | 846 |
|
|
2023
Q4 | $207K | Sell |
8,963
-82,000
| -90% | -$1.9M | ﹤0.01% | 736 |
|
|
2023
Q3 | $727K | Buy |
90,963
+53,820
| +145% | +$430K | 0.01% | 504 |
|
|
2023
Q2 | $323K | Buy |
+37,143
| New | +$323K | ﹤0.01% | 626 |
|